Jul 24
|
Bausch Health Announces the Appointment of Two New Members to Its Board of Directors
|
Jul 15
|
Bausch Health's Xifaxan Patent Clarity, Policy Commentary in Focus for Q2, RBC Says
|
Jul 12
|
Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel
|
Jul 11
|
Chlamydia Market Analysis and Forecast, 2025-2035 Featuring ActivBiotics, Bausch Health, Allergan, WCG Clinical, Hologic, Evofem, CRMI, Meridian Bioscience, Pfizer
|
Jul 2
|
Bausch Health to Announce Second Quarter 2025 Results on July 30
|
Jun 27
|
Marriott Vacations, Bausch Health See Activist Actions
|
Jun 14
|
Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds
|
Jun 10
|
Bausch + Lomb Launching Senior Secured Notes Offering and Refinancing Credit Agreement
|
May 14
|
Bausch Health Announces 2025 Annual Meeting of Shareholder Results
|
Apr 22
|
Bausch Health Learns Icahn Has 34% Economic Interest in Shares
|
Apr 22
|
April 2025's Top Growth Stocks With Strong Insider Ownership
|
Apr 22
|
Bausch Health Announces Filing of Supplement to Proxy Statement
|
Apr 21
|
Bausch (BHC) Moves 13.3% Higher: Will This Strength Last?
|
Apr 19
|
Is Bausch Health Companies (BHC) the Ridiculously Cheap Stock to Invest in?
|
Apr 18
|
3 Reasons to Sell BLCO and 1 Stock to Buy Instead
|
Apr 17
|
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
|
Mar 15
|
Bausch Health announces next steps in financining initiative
|
Mar 14
|
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan
|
Mar 1
|
Bausch Health Companies Inc. (BHC): Among Top Stock Picks From Carl Icahn’s Portfolio
|
Feb 28
|
Bausch Health Plans $5 Billion Debt Sale to Tackle Liabilities
|